D&O Insurance for Companies Going Public
Every route into the public markets changes a company’s liability profile. Whether a private company enters the public markets through a traditional IPO, an uplisting, a cross-listing, a direct listing, or a de-SPAC transaction, directors and officers move into an environment of public disclosure, securities laws, shareholder scrutiny, regulatory oversight, exchange requirements, and increased litigation exposure.
D&O insurance should therefore be part of the going-public workstream, not an administrative purchase left until immediately before listing. Churchwell Insurance Agency helps companies evaluate the transition from private-company D&O to a public-company program and coordinate runoff, effective dates, underwriting, limits, policy wording, and board protection.
D&O insurance for a traditional IPO.
A traditional IPO introduces registration-statement exposure, roadshow and investor communications, underwriting diligence, public financial reporting, and a new shareholder base. The company should review how its private-company D&O policy will respond to pre-IPO wrongful acts and when the new public-company D&O program should become effective.
The insurance process should be coordinated with the company’s legal, finance, accounting, and capital-markets teams. Underwriters may request drafts or near-final versions of registration materials, audited financial statements, capitalization information, use-of-proceeds plans, management biographies, litigation information, governance documents, and other materials relevant to the offering.
D&O insurance for an uplisting.
An uplisting can look less dramatic than an IPO because the company may already be publicly quoted or traded, but moving to a national securities exchange can change investor visibility, trading dynamics, governance requirements, financing opportunities, and underwriting perception. Companies moving from the OTC markets to Nasdaq or NYSE American should review whether their existing D&O program still fits the company they are becoming.
The analysis should include expected market capitalization, anticipated capital raises, shareholder composition, governance changes, exchange compliance, historical disclosure, stock-price volatility, litigation history, and the company’s expected profile after the uplisting.
D&O insurance for a cross-listing.
A foreign or non-U.S. issuer that lists securities in the United States can create additional U.S. securities and litigation exposure. The D&O review should consider the company’s home-country coverage, U.S. listing structure, applicable securities filings, indemnification framework, local policy requirements where relevant, and whether the global program responds consistently across jurisdictions.
D&O insurance for a direct listing.
A direct listing differs from a traditional underwritten IPO in transaction mechanics, but becoming publicly traded still changes the company’s D&O exposure. Public disclosures, securities claims, shareholder litigation, regulatory oversight, and board scrutiny remain important. The insurance program should be designed around the actual listing structure and the company’s post-listing capitalization and risk profile.
D&O insurance for a De-SPAC.
A de-SPAC presents an additional layer because the private operating company is combining with an existing public SPAC. The transaction may involve the target’s private-company D&O, the SPAC’s D&O, runoff for one or both predecessor programs, and a new public-company D&O policy for the combined company. Churchwell maintains a separate De-SPAC D&O resource dedicated to that transition.
What should happen before the listing date?
- Review the current private-company D&O policy and change-in-control provisions.
- Identify any planned runoff or tail coverage for pre-listing exposures.
- Begin public-company D&O underwriting early enough to allow multiple insurers to evaluate the risk.
- Determine appropriate limits, retentions, Side A protection, and excess structure.
- Review policy wording, not just premium.
- Coordinate the effective date with the transaction or listing mechanics.
- Confirm who is responsible for claim notice and policy administration after the company becomes public.
Why the public-company transition matters.
The Professional Liability Underwriting Society treats D&O liability as a discipline involving indemnification, securities and other sources of liability, insurance coverage, claims dynamics, and changing market issues. That is the right way to think about a going-public transaction. Insurance is not merely a certificate or closing deliverable. It is part of the company’s broader framework for protecting directors, officers, and the balance sheet.
Churchwell’s going-public focus.
Churchwell’s Executive Liability Team works with microcap and small-cap public companies and companies preparing to enter the public markets. Chaz Churchwell also hosts The DESPAC Podcast and has appeared on The SPAC Podcast discussing public-company and transaction-related D&O issues. That market involvement helps keep the insurance conversation connected to what attorneys, bankers, auditors, boards, and management teams are seeing in actual transactions.
Planning an IPO, uplisting, cross-listing, direct listing, or de-SPAC? Contact Churchwell early enough to make D&O part of the transaction plan instead of a last-minute closing item.
D&O should be addressed early enough that it is part of the transaction workstream, not a last-minute closing item. Starting early gives the company time to prepare underwriting information, compare markets, negotiate policy language, determine limits, evaluate Side A protection and coordinate runoff of the private-company policy with the effective date of the public-company program.
Yes, a company entering the public markets typically needs a public-company D&O program designed for securities, shareholder, regulatory and disclosure exposures that are different from ordinary private-company risk. The private-company program also needs to be addressed so that pre-IPO wrongful acts are not unintentionally stranded when the new public policy begins.
It can. An uplisting can increase visibility, trading activity, institutional ownership, analyst attention and scrutiny of disclosures and governance. The company should review whether its existing D&O limits, retention, Side A protection and policy wording remain appropriate for its new exchange, market capitalization and investor base.
A direct listing differs from a traditional underwritten IPO, but the company still becomes publicly traded and assumes public-company securities, disclosure and governance exposures. D&O should be evaluated as part of the listing process, including the transition from private-company coverage and the scope of protection for directors, officers and the entity.
A foreign private issuer entering U.S. public markets should evaluate U.S. securities exposure, exchange requirements, the interaction of local and U.S. indemnification rules, policy territory and jurisdiction, claims reporting, Side A protection and how the global insurance program responds to U.S. proceedings. Cross-border programs require careful coordination rather than simply adding a U.S. location to an existing policy.
The private-company policy generally needs to be placed into runoff or otherwise structured to protect against claims based on pre-public wrongful acts, while a new public-company policy becomes effective for the go-forward public entity. The transition date and transaction wording should be documented clearly so the company understands which policy is expected to respond.
Underwriters commonly review financial statements, capitalization, registration or listing materials, management and board backgrounds, business model, risk factors, claims history, projections, transaction structure, use of proceeds, major shareholders, governance, litigation, cyber risk and the company’s public-company readiness. The exact request varies based on the path to market and the carrier.
The registration statement and related public disclosures describe the company, management, financial condition, risk factors and the securities being offered or listed. Because public-company claims can arise from alleged material misstatements or omissions, underwriters closely evaluate the quality, consistency and risk profile reflected in the company’s disclosure record.
Let’s Get Started
Going Public D&O Insurance Quote Request
"*" indicates required fields
Don’t like forms? Contact us at or email us.
